Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
نویسندگان
چکیده
منابع مشابه
Developmental neurotoxicity induced by therapeutic and illicit drugs.
The developmental neurotoxicity of phenytoin, isotretinoin, and methamphetamine has been reviewed to illustrate effects from both therapeutic and illicit drugs to which people are exposed and which either induce or show the potential for inducing learning disabilities following in utero exposure. In each case both human and experimental animal data are presented and compared where possible. The...
متن کاملNeurotoxicity and neuroprotection in Parkinson's disease.
Recent findings of impaired mitochondrial function, altered iron metabolism and increased lipid peroxidation in the substantia nigra in Parkinson's disease emphasize the significance of oxidative stress and free radical formation in the pathogenesis of the disease. Future research will focus on improvements in neuroprotective therapy to prevent or slow the rate of progression of Parkinson's dis...
متن کاملInhaled anesthetic sevoflurane: neurotoxicity or neuroprotection in the developing brain
The practice of pediatric anesthesia has changed during the last 30 years with a noticeable reduction in mortality and serious morbidity. This improvement resulted, in part, from the introduction of a new anesthetic agent called sevoflurane. Recently, data from animal and human studies have shown that sevoflurane may have neurotoxic effects on the developing brain, and these effects can cause s...
متن کاملRole of Exercise and Gdnf in an Animal Model of Parkinsons Disease: Implications for Neuroprotection
Parkinson's disease (PD) is a progressive neurodegenerative disorder resulting in part from loss of nigrostriatal dopamine (DA) neurons. Treatments act only to relieve symptoms. It is therefore essential to develop treatments that slow or reverse the neurodegenerative process. Here, I explored exercise as a potential treatment against a 6-hydroxydopamine (6-OHDA) rat model. 6-OHDA causes select...
متن کاملStriatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by the expansion of a CAG trinucleotide repeat encoding an abnormally long polyglutamine tract (PolyQ) in the huntingtin (Htt) protein. In HD, striking neuropathological changes occur in the striatum, including loss of medium spiny neurons and parvalbumin-expressing interneurons accompanied by neurodegeneration ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Life
سال: 2020
ISSN: 2075-1729
DOI: 10.3390/life10060086